Beaird Harris Wealth Management’s Q32 Bio QTTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9
Closed -$191 625
2023
Q3
$191 Hold
9
﹤0.01% 431
2023
Q2
$145 Hold
9
﹤0.01% 441
2023
Q1
$168 Hold
9
﹤0.01% 462
2022
Q4
$205 Hold
9
﹤0.01% 718
2022
Q3
$0 Hold
9
﹤0.01% 538
2022
Q2
$0 Hold
9
﹤0.01% 644
2022
Q1
$0 Hold
9
﹤0.01% 745
2021
Q4
$1K Buy
+9
New +$874 ﹤0.01% 636

Other funds holding QTTB

Beaird Harris Wealth Management's QTTB Position: Q4 2023 in Review

Beaird Harris Wealth Management sold out of Q32 Bio (QTTB) in Q4 2023, closing a stake of 9 shares — an estimated $191 sold.

Beaird Harris Wealth Management first reported a position in QTTB in Q4 2021 and held it in 8 quarters. The position peaked at $1K in Q4 2021. 57 funds tracked by Wall St. Rank hold QTTB as of Q4 2023.

  • Beaird Harris Wealth Management reported no remaining Q32 Bio position as of Q4 2023 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 9 Q32 Bio shares in Q4 2023, an estimated $191.
  • Beaird Harris Wealth Management first reported a position in Q32 Bio in Q4 2021 and held it in 8 quarters.
  • Beaird Harris Wealth Management's Q32 Bio position peaked at $1K in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2023.

Based on Beaird Harris Wealth Management's 13F filing for Q4 2023, filed 27 Feb 2024.